Huron Consulting Group (NASDAQ:HURN) Releases FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 6.800-7.600 for the period, compared to the consensus estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Huron Consulting Group Stock Up 0.0 %

NASDAQ HURN traded up $0.03 on Tuesday, reaching $125.33. The stock had a trading volume of 396,891 shares, compared to its average volume of 110,694. The business has a 50 day moving average price of $125.65 and a 200 day moving average price of $117.22. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $133.96. The company has a market capitalization of $2.22 billion, a price-to-earnings ratio of 27.25 and a beta of 0.59.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. On average, analysts forecast that Huron Consulting Group will post 6.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Wedbush assumed coverage on Huron Consulting Group in a research note on Monday, February 3rd. They set an “outperform” rating for the company. Benchmark reiterated a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a research note on Wednesday, October 30th. Barrington Research upped their price target on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Huron Consulting Group currently has a consensus rating of “Buy” and an average target price of $133.00.

Insider Buying and Selling

In other Huron Consulting Group news, Director John Mccartney sold 500 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.65, for a total value of $62,325.00. Following the completion of the transaction, the director now owns 56,688 shares of the company’s stock, valued at $7,066,159.20. This represents a 0.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director James H. Roth sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $123.70, for a total value of $247,400.00. Following the completion of the transaction, the director now directly owns 52,825 shares of the company’s stock, valued at approximately $6,534,452.50. This trade represents a 3.65 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,584 shares of company stock valued at $1,067,539. Insiders own 2.02% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.